Dysregulation of miRNA in leukemia: exploiting miRNA expression profiles as biomarkers
L Anelli, A Zagaria, G Specchia, P Musto… - International Journal of …, 2021 - mdpi.com
Micro RNAs (miRNAs) are a class of small non-coding RNAs that have a crucial role in
cellular processes such as differentiation, proliferation, migration, and apoptosis. miRNAs …
cellular processes such as differentiation, proliferation, migration, and apoptosis. miRNAs …
Targeting leukemic stem cells in chronic myeloid leukemia: Is it worth the effort?
S Soverini, S De Santis, C Monaldi, S Bruno… - International journal of …, 2021 - mdpi.com
Chronic myeloid leukemia (CML) is a classical example of stem cell cancer since it arises in
a multipotent hematopoietic stem cell upon the acquisition of the t (9; 22) chromosomal …
a multipotent hematopoietic stem cell upon the acquisition of the t (9; 22) chromosomal …
Treatment-free remission in chronic myeloid leukemia and new approaches by targeting leukemia stem cells
Y Chen, J Zou, F Cheng, W Li - Frontiers in Oncology, 2021 - frontiersin.org
The therapeutic landscape for chronic myeloid leukemia (CML) has improved significantly
with the approval of tyrosine kinase inhibitors (TKIs) for therapeutic use. Most patients with …
with the approval of tyrosine kinase inhibitors (TKIs) for therapeutic use. Most patients with …
Contribution of BCR-ABL molecular variants and leukemic stem cells in response and resistance to tyrosine kinase inhibitors: a review
M Al Hamad - F1000Research, 2022 - pmc.ncbi.nlm.nih.gov
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm generated by reciprocal
chromosomal translocation, t (9; 22)(q34; q11) in the transformed hematopoietic stem cell …
chromosomal translocation, t (9; 22)(q34; q11) in the transformed hematopoietic stem cell …
Properties of leukemic stem cells in regulating drug resistance in acute and chronic myeloid leukemias
X Zhai, X Jiang - Biomedicines, 2022 - mdpi.com
Notoriously known for their capacity to reconstitute hematological malignancies in vivo,
leukemic stem cells (LSCs) represent key drivers of therapeutic resistance and disease …
leukemic stem cells (LSCs) represent key drivers of therapeutic resistance and disease …
CD26/DPP-4 in chronic myeloid leukemia
A Sicuranza, D Raspadori, M Bocchia - Cancers, 2022 - mdpi.com
Simple Summary CD26/dipeptidylpeptidase IV (DPP-4) is a membrane-bound
multifunctional protein expressed in many primary solid tumors and in hematological …
multifunctional protein expressed in many primary solid tumors and in hematological …
Immunophenotypic features of early haematopoietic and leukaemia stem cells
Many tumours are organised in a hierarchical structure with at its apex a cell that can
maintain, establish, and repopulate the tumour—the cancer stem cell. The haematopoietic …
maintain, establish, and repopulate the tumour—the cancer stem cell. The haematopoietic …
MicroRNA: from bench to bedside
J Xiao - 2022 - books.google.com
MicroRNA: From Bench to Bedside provides an in-depth, expansive overview of microRNA
from fundamentals to clinical practice. It presents researchers with detailed insights on the …
from fundamentals to clinical practice. It presents researchers with detailed insights on the …
Profiling of miRNAs and their interfering targets in peripheral blood mononuclear cells from patients with chronic myeloid leukaemia
SC Wu, SW Lai, XJ Lu, HF Lai, YG Chen… - Frontiers in …, 2023 - frontiersin.org
Introduction MicroRNAs may be implicated in the acquisition of drug resistance in chronic
myeloid leukemia as they regulate the expression of not only BCR-ABL1 but also genes …
myeloid leukemia as they regulate the expression of not only BCR-ABL1 but also genes …
Investigating cellular and molecular factors effective in leukemia and analyzing the immune system
N Sahraei, M Mobin Rahni… - … and Biopharma (HBB), 2022 - healthbiotechpharm.org
Leukemia as one of the common cancers is still studied and needs improvement in
diagnosis and treatment. In this study, we examined the activity of hematopoietic stem cells …
diagnosis and treatment. In this study, we examined the activity of hematopoietic stem cells …